{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,8,26]],"date-time":"2026-08-26T06:47:22Z","timestamp":1787726842995,"version":"build-2784847793"},"reference-count":22,"publisher":"Ovid Technologies (Wolters Kluwer Health)","issue":"12","content-domain":{"domain":["neurology.org"],"crossmark-restriction":true},"short-container-title":["Neurology"],"published-print":{"date-parts":[[2013,3,19]]},"DOI":"10.1212\/wnl.0b013e3182886965","type":"journal-article","created":{"date-parts":[[2013,2,28]],"date-time":"2013-02-28T19:43:52Z","timestamp":1362080632000},"page":"1086-1094","update-policy":"https:\/\/doi.org\/10.1212\/crossmarkpolicy","source":"Crossref","is-referenced-by-count":19,"title":["One-year safety and tolerability profile of pridopidine in patients with Huntington disease"],"prefix":"10.1212","volume":"80","author":[{"given":"Ferdinando","family":"Squitieri","sequence":"first","affiliation":[{"name":"From the Centre for Neurogenetics and Rare Diseases (F.S.), IRCCS Neuromed, Pozzilli, Italy; Department of Neurology (B.L.), University of Ulm, Ulm; Department of Neurology (R.R.), University of M\u00fcnster, M\u00fcnster, Germany; Neuroscience Division (A.R.), School of Biosciences, University of Cardiff, Cardiff, UK; Department of Neurology (J.G.d.Y.), Hospital Ram\u00f3n y Cajal, Madrid, Spain; NeuroSearch A\/S (A.P., J.I., \u00c5R.), Ballerup, Denmark; and Oxford PharmaGenesis Ltd. (J.B.), Tubney, UK."}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Bernhard","family":"Landwehrmeyer","sequence":"additional","affiliation":[{"name":"From the Centre for Neurogenetics and Rare Diseases (F.S.), IRCCS Neuromed, Pozzilli, Italy; Department of Neurology (B.L.), University of Ulm, Ulm; Department of Neurology (R.R.), University of M\u00fcnster, M\u00fcnster, Germany; Neuroscience Division (A.R.), School of Biosciences, University of Cardiff, Cardiff, UK; Department of Neurology (J.G.d.Y.), Hospital Ram\u00f3n y Cajal, Madrid, Spain; NeuroSearch A\/S (A.P., J.I., \u00c5R.), Ballerup, Denmark; and Oxford PharmaGenesis Ltd. (J.B.), Tubney, UK."}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ralf","family":"Reilmann","sequence":"additional","affiliation":[{"name":"From the Centre for Neurogenetics and Rare Diseases (F.S.), IRCCS Neuromed, Pozzilli, Italy; Department of Neurology (B.L.), University of Ulm, Ulm; Department of Neurology (R.R.), University of M\u00fcnster, M\u00fcnster, Germany; Neuroscience Division (A.R.), School of Biosciences, University of Cardiff, Cardiff, UK; Department of Neurology (J.G.d.Y.), Hospital Ram\u00f3n y Cajal, Madrid, Spain; NeuroSearch A\/S (A.P., J.I., \u00c5R.), Ballerup, Denmark; and Oxford PharmaGenesis Ltd. (J.B.), Tubney, UK."}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Anne","family":"Rosser","sequence":"additional","affiliation":[{"name":"From the Centre for Neurogenetics and Rare Diseases (F.S.), IRCCS Neuromed, Pozzilli, Italy; Department of Neurology (B.L.), University of Ulm, Ulm; Department of Neurology (R.R.), University of M\u00fcnster, M\u00fcnster, Germany; Neuroscience Division (A.R.), School of Biosciences, University of Cardiff, Cardiff, UK; Department of Neurology (J.G.d.Y.), Hospital Ram\u00f3n y Cajal, Madrid, Spain; NeuroSearch A\/S (A.P., J.I., \u00c5R.), Ballerup, Denmark; and Oxford PharmaGenesis Ltd. (J.B.), Tubney, UK."}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Justo Garcia","family":"de Yebenes","sequence":"additional","affiliation":[{"name":"From the Centre for Neurogenetics and Rare Diseases (F.S.), IRCCS Neuromed, Pozzilli, Italy; Department of Neurology (B.L.), University of Ulm, Ulm; Department of Neurology (R.R.), University of M\u00fcnster, M\u00fcnster, Germany; Neuroscience Division (A.R.), School of Biosciences, University of Cardiff, Cardiff, UK; Department of Neurology (J.G.d.Y.), Hospital Ram\u00f3n y Cajal, Madrid, Spain; NeuroSearch A\/S (A.P., J.I., \u00c5R.), Ballerup, Denmark; and Oxford PharmaGenesis Ltd. (J.B.), Tubney, UK."}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Allan","family":"Prang","sequence":"additional","affiliation":[{"name":"From the Centre for Neurogenetics and Rare Diseases (F.S.), IRCCS Neuromed, Pozzilli, Italy; Department of Neurology (B.L.), University of Ulm, Ulm; Department of Neurology (R.R.), University of M\u00fcnster, M\u00fcnster, Germany; Neuroscience Division (A.R.), School of Biosciences, University of Cardiff, Cardiff, UK; Department of Neurology (J.G.d.Y.), Hospital Ram\u00f3n y Cajal, Madrid, Spain; NeuroSearch A\/S (A.P., J.I., \u00c5R.), Ballerup, Denmark; and Oxford PharmaGenesis Ltd. (J.B.), Tubney, UK."}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jelena","family":"Ivkovic","sequence":"additional","affiliation":[{"name":"From the Centre for Neurogenetics and Rare Diseases (F.S.), IRCCS Neuromed, Pozzilli, Italy; Department of Neurology (B.L.), University of Ulm, Ulm; Department of Neurology (R.R.), University of M\u00fcnster, M\u00fcnster, Germany; Neuroscience Division (A.R.), School of Biosciences, University of Cardiff, Cardiff, UK; Department of Neurology (J.G.d.Y.), Hospital Ram\u00f3n y Cajal, Madrid, Spain; NeuroSearch A\/S (A.P., J.I., \u00c5R.), Ballerup, Denmark; and Oxford PharmaGenesis Ltd. (J.B.), Tubney, UK."}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jeremy","family":"Bright","sequence":"additional","affiliation":[{"name":"From the Centre for Neurogenetics and Rare Diseases (F.S.), IRCCS Neuromed, Pozzilli, Italy; Department of Neurology (B.L.), University of Ulm, Ulm; Department of Neurology (R.R.), University of M\u00fcnster, M\u00fcnster, Germany; Neuroscience Division (A.R.), School of Biosciences, University of Cardiff, Cardiff, UK; Department of Neurology (J.G.d.Y.), Hospital Ram\u00f3n y Cajal, Madrid, Spain; NeuroSearch A\/S (A.P., J.I., \u00c5R.), Ballerup, Denmark; and Oxford PharmaGenesis Ltd. (J.B.), Tubney, UK."}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"\u00c5sa","family":"Rembratt","sequence":"additional","affiliation":[{"name":"From the Centre for Neurogenetics and Rare Diseases (F.S.), IRCCS Neuromed, Pozzilli, Italy; Department of Neurology (B.L.), University of Ulm, Ulm; Department of Neurology (R.R.), University of M\u00fcnster, M\u00fcnster, Germany; Neuroscience Division (A.R.), School of Biosciences, University of Cardiff, Cardiff, UK; Department of Neurology (J.G.d.Y.), Hospital Ram\u00f3n y Cajal, Madrid, Spain; NeuroSearch A\/S (A.P., J.I., \u00c5R.), Ballerup, Denmark; and Oxford PharmaGenesis Ltd. (J.B.), Tubney, UK."}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"276","reference":[{"key":"e_1_3_8_2_2","doi-asserted-by":"publisher","DOI":"10.1016\/S0140-6736(07)60111-1"},{"key":"e_1_3_8_3_2","doi-asserted-by":"publisher","DOI":"10.1093\/brain\/awn025"},{"key":"e_1_3_8_4_2","doi-asserted-by":"publisher","DOI":"10.1007\/s004010051037"},{"key":"e_1_3_8_5_2","doi-asserted-by":"publisher","DOI":"10.1093\/brain\/awm217"},{"key":"e_1_3_8_6_2","doi-asserted-by":"publisher","DOI":"10.1002\/ana.410260103"},{"key":"e_1_3_8_7_2","doi-asserted-by":"publisher","DOI":"10.1136\/jnnp.56.5.487"},{"key":"e_1_3_8_8_2","first-page":"215","article-title":"Brain white-matter volume loss and glucose hypometabolism precede the clinical symptoms of Huntington\u2019s disease","volume":"47","author":"Ciarmiello A","year":"2006","unstructured":"Ciarmiello A, Cannella M, Lastoria S, et al.. Brain white-matter volume loss and glucose hypometabolism precede the clinical symptoms of Huntington\u2019s disease. J Nucl Med 2006;47:215\u2013222.","journal-title":"J Nucl Med"},{"key":"e_1_3_8_9_2","doi-asserted-by":"publisher","DOI":"10.1212\/01.WNL.0000086373.32347.16"},{"key":"e_1_3_8_10_2","first-page":"CD006456","article-title":"Therapeutic interventions for symptomatic treatment in Huntington\u2019s disease","volume":"3","author":"Mestre T","year":"2009","unstructured":"Mestre T, Ferreira J, Coelho MM, Rosa M, Sampaio C. Therapeutic interventions for symptomatic treatment in Huntington\u2019s disease. Cochrane Database Syst Rev 2009;3:CD006456.","journal-title":"Cochrane Database Syst Rev"},{"key":"e_1_3_8_11_2","first-page":"CD006455","article-title":"Therapeutic interventions for disease progression in Huntington's disease","volume":"3","author":"Mestre T","year":"2009","unstructured":"Mestre T, Ferreira J, Coelho MM, Rosa M, Sampaio C. Therapeutic interventions for disease progression in Huntington's disease. Cochrane Database Syst Rev 2009;3:CD006455.","journal-title":"Cochrane Database Syst Rev"},{"key":"e_1_3_8_12_2","first-page":"RRN1260","article-title":"An international survey-based algorithm for the pharmacologic treatment of chorea in Huntington\u2019s disease","volume":"3","author":"Burgunder J-M","year":"2011","unstructured":"Burgunder J-M, Guttman M, Perlman S, et al.. An international survey-based algorithm for the pharmacologic treatment of chorea in Huntington\u2019s disease. Plos Curr Epub 2011;3:RRN1260.","journal-title":"Plos Curr Epub"},{"key":"e_1_3_8_13_2","doi-asserted-by":"publisher","DOI":"10.1192\/bjp.bp.111.101485"},{"key":"e_1_3_8_14_2","doi-asserted-by":"publisher","DOI":"10.1016\/j.ejphar.2009.11.025"},{"key":"e_1_3_8_15_2","doi-asserted-by":"publisher","DOI":"10.1016\/j.ejphar.2010.07.023"},{"key":"e_1_3_8_16_2","first-page":"33","article-title":"Pridopidine: effects on corticostriatal pathways controlling motor functions","volume":"80","author":"Waters S","year":"2011","unstructured":"Waters S, Klamer D, Tedroff J, et al.. Pridopidine: effects on corticostriatal pathways controlling motor functions. Clin Genet 2011;80(suppl 1):33.","journal-title":"Clin Genet"},{"key":"e_1_3_8_17_2","doi-asserted-by":"publisher","DOI":"10.1002\/mds.870110204"},{"key":"e_1_3_8_18_2","doi-asserted-by":"publisher","DOI":"10.1016\/S1474-4422(11)70233-2"},{"key":"e_1_3_8_19_2","unstructured":"ICH Expert Working Group. Clinical safety data management: definitions and standards for expedited reporting-E2a ICH Harmonised Tripartite Guideline. International Conference on Harmonisation of Technical Requirements for Registration of Pharmaceuticals for Human Use. Available at: http:\/\/www.ich.org\/fileadmin\/Public_Web_Site\/ICH_Products\/Guidelines\/Efficacy\/E2A\/Step4\/E2A_Guideline.pdf. Accessed October 31 2012."},{"key":"e_1_3_8_20_2","doi-asserted-by":"publisher","DOI":"10.1016\/j.nurt.2009.10.003"},{"key":"e_1_3_8_21_2","first-page":"135","article-title":"A randomized, double-blind placebo-controlled trial of ACR16 in Huntington\u2019s disease","volume":"8","author":"Kieburtz K","year":"2011","unstructured":"Kieburtz K, on behalf of the HSG HART study investigators. A randomized, double-blind placebo-controlled trial of ACR16 in Huntington\u2019s disease. Neurotherapeutics 2011;8:135.","journal-title":"Neurotherapeutics"},{"key":"e_1_3_8_22_2","doi-asserted-by":"publisher","DOI":"10.1176\/appi.ajp.162.4.725"},{"key":"e_1_3_8_23_2","unstructured":"World Health Organization. Mental health: country reports [online]. Available at: http:\/\/www.who.int\/mental_health\/prevention\/suicide\/country_reports\/en\/. Accessed October 31 2012."}],"container-title":["Neurology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.neurology.org\/doi\/pdfdirect\/10.1212\/WNL.0b013e3182886965","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2024,3,28]],"date-time":"2024-03-28T10:43:08Z","timestamp":1711622588000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.neurology.org\/doi\/10.1212\/WNL.0b013e3182886965"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2013,3,19]]},"references-count":22,"journal-issue":{"issue":"12","published-print":{"date-parts":[[2013,3,19]]}},"alternative-id":["10.1212\/WNL.0b013e3182886965"],"URL":"https:\/\/doi.org\/10.1212\/wnl.0b013e3182886965","relation":{"has-review":[{"id-type":"doi","id":"10.3410\/f.717995371.793474519","asserted-by":"object"},{"id-type":"doi","id":"10.3410\/f.717995371.793475368","asserted-by":"object"},{"id-type":"doi","id":"10.3410\/f.717995371.793475705","asserted-by":"object"}]},"ISSN":["0028-3878","1526-632X"],"issn-type":[{"value":"0028-3878","type":"print"},{"value":"1526-632X","type":"electronic"}],"subject":[],"published":{"date-parts":[[2013,3,19]]}}}